TY - JOUR
T1 - Topically Applied Therapies for the Treatment of Skin Disease
T2 - Past, Present, and Future
AU - Brown, Marc
AU - Williams, Adrian
AU - Chilcott, Robert P.
AU - Brady, Brendan
AU - Lenn, Jon
AU - Evans, Charles
AU - Allen, Lynn
AU - McAuley, William J.
AU - Beebeejaun, Mubinah
AU - Haslinger, Jasmin
AU - Beuttel, Claire
AU - Vieira, Raquel
AU - Guidali, Florencia
AU - Miranda, Margarida
N1 - Publisher Copyright:
© 2024 by The American Society for Pharmacology and Experimental Therapeutics.
PY - 2024/9/1
Y1 - 2024/9/1
N2 - The purpose of this review is to summarize essential biological, pharmaceutical, and clinical aspects in the field of topically applied medicines that may help scientists when trying to develop new topical medicines. After a brief history of topical drug delivery, a review of the structure and function of the skin and routes of drug absorption and their limitations is provided. The most prevalent diseases and current topical treatment approaches are then detailed, the organization of which reflects the key disease categories of autoimmune and inflammatory diseases, microbial infections, skin cancers, and genetic skin diseases. The complexity of topical product development through to large-scale manufacturing along with recommended risk mitigation approaches are then highlighted. As such topical treatments are applied externally, patient preferences along with the challenges they invoke are then described, and finally the future of this field of drug delivery is discussed, with an emphasis on areas that are more likely to yield significant improvements over the topical medicines in current use or would expand the range of medicines and diseases treatable by this route of administration.
AB - The purpose of this review is to summarize essential biological, pharmaceutical, and clinical aspects in the field of topically applied medicines that may help scientists when trying to develop new topical medicines. After a brief history of topical drug delivery, a review of the structure and function of the skin and routes of drug absorption and their limitations is provided. The most prevalent diseases and current topical treatment approaches are then detailed, the organization of which reflects the key disease categories of autoimmune and inflammatory diseases, microbial infections, skin cancers, and genetic skin diseases. The complexity of topical product development through to large-scale manufacturing along with recommended risk mitigation approaches are then highlighted. As such topical treatments are applied externally, patient preferences along with the challenges they invoke are then described, and finally the future of this field of drug delivery is discussed, with an emphasis on areas that are more likely to yield significant improvements over the topical medicines in current use or would expand the range of medicines and diseases treatable by this route of administration.
UR - http://www.scopus.com/inward/record.url?scp=85201437747&partnerID=8YFLogxK
U2 - 10.1124/pharmrev.123.000549
DO - 10.1124/pharmrev.123.000549
M3 - Article
C2 - 38914467
AN - SCOPUS:85201437747
SN - 0031-6997
VL - 76
SP - 689
EP - 790
JO - Pharmacological Reviews
JF - Pharmacological Reviews
IS - 5
ER -